Patients like Sharon are counting on lawmakers to fix Medicare [Video]

Peter M. Riedell, MD, University of Chicago Medicine, Chicago, IL, shares updates from the Phase III ZUMA-7 trial (NCT03391466) of the anti CD19 axicabtagene ciloleucel (axi-cel), a chimeric antigen receptor (CAR) T-cell therapy in patients with relapsed/refractory (r/r) large B-cell lymphoma (LBCL). A superior event-free survival and overall survival were reported in the axi-cel arm and the findings corroborate with data from the Phase III TRANSFORM trial (NCT03575351), demonstrating the potential of CAR T-cell therapy as a second-line option for LBCL. This interview took place at the 63rd ASH Annual Meeting and Exposition congress in Atlanta, GA.

Hi All!I'm Andy McAslan, and through this channel we'll be telling the story of my journey through cancer. I have a rare blood cancer called follicular lymphma, and me and my partner Leah will be documenting the highs and lows as two young people tackle this together. Welcome to the journey!

A 7-year-old Woodland boy diagnosed with leukemia wished to meet Santa Claus and have a hamburger dinner at the North Poleand that wish was granted.

Seneca Valley High School's football team is learning the greatest lessons in life this year.